Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder

Archives of Women's Mental Health

Volumn 19, Issue 6, 2016, Pages 953-958

  Ismaili, Elgerta ^a   Walsh, Sally ^a   O’Brien, Patrick Michael Shaughn ^b   Bäckström, Torbjorn ^c   Brown, Candace ^d   Dennerstein, Lorraine ^e   Eriksson, Elias ^f   Freeman, Ellen W ^g   Ismail, Khaled M K ^h   Panay, Nicholas ⁱ   Pearlstein, Teri ^j   Rapkin, Andrea ^k   Steiner, Meir ^l   Studd, John ⁱ   Sundström Paromma, Inger ^m   Endicott, Jean ⁿ   Epperson, C Neill ^o   Halbreich, Uriel ^p   Reid, Robert ^q   Rubinow, David ^r   Schmidt, Peter ^s   Yonkers, Kimberley ^o   Consensus Group of the International Society for Premenstrual Disorders, ^t   more..

^a UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^b KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF BIRMINGHAM   (United Kingdom)

ⁱ CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^j BROWN UNIVERSITY   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l MCMASTER UNIVERSITY   (Canada)

^m UPPSALA UNIVERSITY   (Sweden)

ⁿ Och Spine at New York Presbyterian Hospitals   (United States)

^o YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY AT BUFFALO   (United States)

^q QUEEN S UNIVERSITY   (Canada)

^r UNIVERSITY OF NORTH CAROLINA   (United States)

^s NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^t National Institute of Mental Health ^*

more..

Author keywords

PMD (premenstrual disorder); PMDD (premenstrual disorder premenstrual dysphoric disorder); PMS (premenstrual syndrome)

Indexed keywords

ESTROGEN; GONADORELIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CLINICAL AUDIT; CONSENSUS; FEMALE; HUMAN; HYSTERECTOMY; INTERNATIONAL SOCIETY OF PREMENSTRUAL DISORDERS; MEDICAL SOCIETY; MENSTRUAL CYCLE; MENSTRUATION; MENSTRUATION DISORDER; OVULATION INHIBITION; PATIENT CARE; PREMENSTRUAL DISORDER; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; HEALTH CARE QUALITY; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT; PROCEDURES; STANDARD; STANDARDS;

COMMISSION ON PROFESSIONAL AND HOSPITAL ACTIVITIES; CONSENSUS; FEMALE; HUMANS; INTERNATIONAL COOPERATION; PATIENT CARE MANAGEMENT; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; REFERENCE STANDARDS; STANDARD OF CARE;

EID: 84976902064     PISSN: 14341816     EISSN: 14351102     Source Type: Journal    
DOI: 10.1007/s00737-016-0631-7     Document Type: Article

References (17)

1. American College Obstetricians and Gynecologists, ACOG (2011) Premenstrual syndrome 57(3). http://www.acog.org/Patients/FAQs/Premenstrual-Syndrome-PMS
2. Borenstein JE, Dean BB, Yonkers KA, Endicott (2007) Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. Obstet Gynecol 109:1068–75
3. Brown J, O’Brien PMS, Marjoribanks J, Wyatt K (2009) Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2:CD001396
4. Dickerson L, Mazuck P, Hunter M (2003) Premenstrual syndrome. Am Fam Physician 67(8):1743–1752
5. Dimmock PW, Wyatt KM, Jones PW, O’Brien PM (2000) Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome; a systematic review. Lancet 356:1131–1136
6. Ismail K, Nevatte T, O’Brien PMS, Paschetta E, Bäckström T (2013) Clinical subtypes of core premenstrual disorders: a Delphi survey. Arch Womens Ment Health 16:197–201
7. Kadian S, O’Brien S (2012) Classification of premenstrual disorders as proposed by the International Society for Premenstrual Disorders. Menopause Int 18:43–7
8. Lopez LM, Kaptein AA, Helmerhorst FM (2012) Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev (Issue 2). Art. No.: CD006586
9. Nevatte T, O’Brien PMS, Backstrom T, Brown C et al (2013) ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health 16:279–291
10. O’Brien PMS, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN et al (2011) Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health 14:13–21
11. Panay N (2009) Management of premenstrual syndrome. Br Med J 35(3):187–194
12. Rapkin AJ, Kuo J (2007) Neurotransmitter physiology: the basics for understanding premenstrual syndrome. In: O’Brien PMS, Rapkin A, Schmidt P (eds) The premenstrual syndromes: PMS and PMDD. Informa Healthcare, London, pp 69–71
13. Royal College of Obstetricians and Gynaecologists. Premenstrual syndrome, management (Green-top Guideline No. 48). London:RCOG (2007) https://www.rcog.org.uk/en/guidelines-researchservices/guidelines/gtg48/.
14. Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borensstein J (2008) Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol 111:1175–1182
15. Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O’Brien PM (2004) The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta-analysis. BJOG 111:585–593
16. Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A (2005) Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 106:492–501
17. Yonkers K, O’Brien PMS, Eriksson E (2008) Premenstrual syndrome. PubMed 10:1200–1210